Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Exercise/Conversion of 302 TARS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 302 | n/a |
| Jun 29, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 3,837 | n/a |
| Jun 18, 2026 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 20,000 | n/a |
| Jun 16, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 2,954 | n/a |
| May 21, 2026 | INOVIO PHARMACEUTICALS, INC. (INO) | Grant/Award | 41,800 | n/a |
| Jun 26, 2025 | IDEAYA Biosciences, Inc. (IDYA) | Grant/Award | 20,000 | n/a |
| Jun 17, 2025 | IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | Grant/Award | 67,546 | n/a |
| Jun 16, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 3,350 | n/a |
| May 21, 2025 | INOVIO PHARMACEUTICALS, INC. (INO) | Exercise/Conversion | 2,167 | n/a |
| Jun 25, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 3,350 | n/a |